BioCardia, Inc. logo

BioCardia, Inc.

BCDA

NASDAQHealthcareBiotechnology

Regular session

$1.00

−$0.01 · -0.99%

Aug 24, 1:40 PM ET

BCDA company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

18

Overpriced

Momentum

22

Weakening

Sentiment

64

Bullish

Risk resilience

37

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $1.00

52-week range

Current $1.00

Open
$1.01
Previous close
$1.01
Volume
158.48K
Market cap
14.88M USD
50-day average
$0.9466
+5.64% above average
200-day average
$1.146
-12.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
6.37M USD
P/E (TTM)
-1.34×
P/B (TTM)
4.57×
P/S (TTM)
EV / EBITDA
-0.82×
Earnings yield
-98.73%
Free cash flow yield
-89.31%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
0.00%
Operating margin
0.00%
Net margin
0.00%
Return on equity
-919.33%
Return on assets
-241.08%
Return on invested capital
-581.73%

Financial health

Debt / equity
0.11×
Current ratio
1.12×
Altman Z-score
-50.84
Piotroski F-score
1 of 9

Earnings

EPS beat rate
64%
7 beats, 4 misses, 0 met estimates
Average EPS surprise
-56.35%
11 comparable reports
Latest EPS result
-0.13
Estimate -0.18 · Beat by 27.78%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.05-0.35-0.64-0.93Q1 '25BeatQ2 '25MissQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 26, 2025: actual -0.25, estimate -0.87, surprise +71.26%, Beat. Q2 2025, reported May 14, 2025: actual -0.59, estimate -0.39, surprise -51.28%, Miss. Q3 2025, reported Aug 11, 2025: actual -0.4, estimate -0.25, surprise -60.00%, Miss. Q4 2025, reported Nov 12, 2025: actual -0.24, estimate -0.25, surprise +4.00%, Beat. Q1 2026, reported Mar 24, 2026: actual -0.06, estimate -0.2, surprise +70.00%, Beat. Q2 2026, reported May 15, 2026: actual -0.21, estimate -0.17, surprise -23.53%, Miss. Q3 2026, reported Aug 12, 2026: actual -0.13, estimate -0.18, surprise +27.78%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate -0.15, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates96.96K65.49K34.02K2.55KQ1 '24MissQ2 '24No estimateQ3 '24MissQ4 '24BeatQ1 '25BeatQ1 '26Estimate
Q1 2024, reported Mar 27, 2024: actual 13K USD, estimate 90K USD, surprise -85.56%, Miss. Q2 2024, reported May 14, 2024: actual 55K USD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 13, 2024: actual 3K USD, estimate 50K USD, surprise -94.00%, Miss. Q4 2024, reported Nov 13, 2024: actual 58K USD, estimate 20K USD, surprise +190.00%, Beat. Q1 2025, reported Mar 26, 2025: actual 25K USD, estimate 22.5K USD, surprise +11.11%, Beat. Q1 2026, reported Mar 24, 2026: actual —, estimate 25K USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

5 ratings
Strong buy00%
Buy480%
Hold120%
Sell00%
Strong sell00%

Recent analyst actions

1 institution

BCDA news

Corporate actions

Corporate action history

Stock split

Effective May 30, 2024

1:15

Stock split

Effective Jun 6, 2019

1:9

Stock split

Effective Nov 3, 2017

1:12

Stock split

Effective Mar 14, 2008

1:10

Stock split

Effective Jan 6, 2004

6:1

Stock split

Effective Aug 23, 2001

1:3

BCDA peers

ETFs holding BCDA

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research BCDA

research.disclaimer